Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tdinovo who wrote (10858)	11/7/1997 10:15:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Ted, Historically, Nov, Dec, and Jan are the best months for stocks and everyone knows how bad Oct can be. I think that many viewed today's dip as the last chance to get these stocks at low prices. Biotechs lately have used Dec and Jan to mount some impressive gains and LGND still has quite a bit of news to put out (including the three popular press articles which are still on some editor's desk). Baby Boomers know where the growth industry of the future lies, and reports come out daily which portend major spending on health, and Biotechs will be coming out with novel and expensive treatments which will expand and create markets. Its easy to get caught up in the day to day (or on days like this the minute to minute) changes, but long term, the stronger Biotechs should do very well, with LGND leading the charge as more and more Biotechs move toward profitability as the sector matures. The two big markets that keep appearing day after day in the papers is the diabetes epidemic expanding due to lifestyle changes associated with a sedentary aging population that is becoming increasingly stressed out as well as osteoporosis, primarily in women, but also in men. The entire metabolic disease area is exploding and LGND is well positioned to benefit in the short and long term.